BRISBANE, Calif. (AP) _ Aimmune Therapeutics Inc. (AIMT) on Thursday reported a loss of $69.2 million in its second quarter.
The Brisbane, California-based company said it had a loss of $1.06 per share.
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for a loss of $1.06 per share.
Aimmune Therapeutics shares have decreased 58% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $14.04, a decline of 29% in the last 12 months.